Business Context and Reporting Period
Company: MacroGenics, Inc. (MGNX)
Filing Type: Form 8-K (Current Report)
Date: March 10, 2023
Item: 7.01 Regulation FD Disclosure
This filing addresses investor concerns regarding the company's exposure to the Silicon Valley Bank (SVB) crisis. MacroGenics, Inc. is a biopharmaceutical company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report is limited to a disclosure regarding the location of cash deposits.
Material Changes
No material financial changes or operational updates are reported in this document. The filing serves solely to clarify the company's banking relationships in the context of the SVB situation.
Guidance, Outlook, and Risks
Management Commentary: The company explicitly states that it does not hold cash deposits or securities at Silicon Valley Bank. This disclosure was made to mitigate investor risk perception regarding potential liquidity constraints or asset losses associated with SVB.
Investor Verification Checklist
- Verify the company's total cash and cash equivalents position in the most recent 10-Q or 10-K filing.
- Confirm the list of primary banking institutions where the company holds deposits.
- Review subsequent filings for any updates on liquidity or capital raise activities.